SABA inhaler carbon emissions drop by one-third
NHS England data has shown that average emissions for short-acting beta-2 agonist (SABA) inhalers prescribed in primary care declined by 33% between 2020 and November 2024 — from 24.2 kgCO2e to 16.1 kgCO2e. The Pharmaceutical Journal reports that this fall in SABA inhaler emissions most likely owes to patients switching from the Ventolin Evohaler to the Salamol inhaler.
NICE has produced a decision aid on asthma inhalers and climate change. It explains the options for patients thinking about reducing the carbon footprint of their asthma treatment and the options available.
Related Posts
National Pensions Awareness Week 2024
GP pension campaign in England At the end of July, the BMA’s pensions committee launched a campaign to assist GPs…
BMA Local Event – Resilience and Well-Being for Doctors
Doctors experience difficult and emotionally challenging situations in the front line of healthcare. It is therefore crucial that the inherent…
NHS England’s Targeted Lung Health Check (TLHC) Programme renamed as Lung Cancer Screening
From 1 February 2025, following research recommending the change, the Targeted Lung Health Check (TLHC) Programme will be known as…